PEOPLE - Calypte Biomedical (US) makes appointment:
This article was originally published in Clinica
Pleasanton, California-based in vitro diagnostic tests developer Calypte Biomedical has announced that president and CEO Richard George has assumed the role of chairman of the technology committee. His election is as a result of the resignation for personal reasons of Zafar Randawa, who had been a member of the board of directors since December 1996.
You may also be interested in...
Health-system pharmacist organization assesses the evidence behind off-label use of existing drugs for COVID-19, along with top investigational prospects like Gilead’s remdesivir.
As American auto giants GM and Ford take the wheel on working with ventilator manufacturers to make the critically needed devices during the COVID-19 pandemic, two longtime quality experts explain where the device and auto companies will find common ground when it comes to quality systems.
Despite a reprieve last summer from the Trump administration’s proposed drug price rebate rule, speakers at the 25th annual Pharmacy Benefit Manager Institute kept the focus on price transparency and talked up new ways to manage drug costs for patients in need of treatment.